Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
George O'Brien
ID:
1b834089-2619-30fb-68c4
/
Unclaimed
/
Organization:
Hogan Lovells
Published Works
9 articles
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision in Novartis AG v. Lee alters patent term adjustment
Focus on Regulation ·
February 27, 2014
cite
Europe approves its first mAb biosimilar & FDA is handling 17 biosimilar INDs
Biosimilars Law Blog ·
October 7, 2013
cite
FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity
Focus on Regulation ·
October 1, 2012
cite
Public Comment on FDA Draft Biosimilars Guidances
Biosimilars Law Blog ·
February 29, 2012
cite
Previous
1
2
Next